Skip to search formSkip to main contentSkip to account menu

Keppra

Known as: UCB Brand of Levetiracetam 
National Institutes of Health

Related topics

Related topics

6 relations
24 HR Levetiracetam 750 MG Extended Release Oral Tablet [Keppra]Kao-TinLevetiracetamLevetiracetam 500 MG Oral Tablet [Keppra]

Broader (1)

etiracetam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Levetiracetam (Keppra), urinary retention and literature search.
To the Editor Levetiracetam (Keppra) is being used to treat epilepsy and has been available as a generic drug in the UK since… 
2015
2015
MP19-06 MESENCHYMAL STEM-CELL THERAPY ALLEVIATES INTERSTITIAL CYSTITIS BY ACTIVATING WNT SIGNALING PATHWAY
2012
2012
Preoperative chemotherapy for bladder cancer
Surprisingly, a higher proportion of patients(22%) received AC. A mere 9% of all patients received cisplatin-based NC… 
2010
2010
Discovery of Indolone Acetamides as Novel SV2A Ligands with Improved Potency Toward Seizure Suppression
A major goal in epilepsy research is to develop new antiepileptic drugs (AEDs) that combine improved seizure control with… 
2009
2009
A Pilot Study of Reduced Intensity Conditioning (RI) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor…
2008
2008
Dangerous Liouville Wave - Exactly marginal but non-conformal deformation
We give a non-trivially interacting field theory example of scale invariant but non-conformal field theory. The model is based on… 
2002
2002
Levetiracetam monotherapy for adults with localization-related epilepsy
1997
1997
Inhibition by levetiracetam of a non‐GABAA receptor‐associated epileptiform effect of bicuculline in rat hippocampus
1 Extracellular recording of field potentials, evoked by commissural stimulation in hippocampal area CA3 of anaesthetized rats… 
1996
1996
Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy
1995
1995
THE PHARMACOKINETICS OF LEVETIRACETAM (UCB LO59) IN PATIENTS WITH INTRACTABLE EPILEPSY
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)